Exagen Inc. (XGN)

NASDAQ: XGN · IEX Real-Time Price · USD
4.62
-0.02 (-0.43%)
May 24, 2022 4:00 PM EDT - Market closed

Cash Flow Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year20212020201920182017
Net Income
-26.85-16.69-12.04-8.01-25.63
Depreciation & Amortization
0.950.550.590.730.67
Share-Based Compensation
4.732.690.570.110.19
Other Operating Activities
0.91-0.641.16-2.1313.81
Operating Cash Flow
-20.27-14.08-9.71-9.3-10.97
Capital Expenditures
-2.37-0.46-0.1-0.2-0.51
Other Investing Activities
-0.050000
Investing Cash Flow
-2.42-0.46-0.1-0.2-0.51
Share Issuance / Repurchase
65.250.1750.4400
Debt Issued / Paid
-0.53-0.25-0.144.964.51
Other Financing Activities
-0.04-0.0218.436.4714.64
Financing Cash Flow
64.68-0.168.7311.4219.16
Net Cash Flow
41.99-14.6458.921.927.68
Free Cash Flow
-22.64-14.54-9.81-9.5-11.48
Free Cash Flow Margin
-46.87%-34.64%-24.30%-29.28%-42.82%
Free Cash Flow Per Share
-1.42-1.15-2.74-150.78-182.18
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).